Scott Robert Henry Sells 3,000 Shares of NEXGEL, Inc. (NASDAQ:NXGL) Stock

NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry sold 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $3.37, for a total value of $10,110.00. Following the completion of the sale, the director now owns 141,553 shares in the company, valued at approximately $477,033.61. This represents a 2.08 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Scott Robert Henry also recently made the following trade(s):

• On Friday, December 20th, Scott Robert Henry sold 3,000 shares of NEXGEL stock. The shares were sold at an average price of $4.64, for a total value of $13,920.00.

NEXGEL Price Performance

Shares of NASDAQ:NXGL traded down $0.08 on Wednesday, hitting $3.43. The stock had a trading volume of 54,245 shares, compared to its average volume of 259,265. The firm’s 50 day moving average price is $3.70 and its 200-day moving average price is $3.00. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.93 and a current ratio of 1.51. NEXGEL, Inc. has a twelve month low of $1.84 and a twelve month high of $5.10. The company has a market capitalization of $23.29 million, a price-to-earnings ratio of -5.91 and a beta of 0.61.

Institutional Trading of NEXGEL

A hedge fund recently raised its stake in NEXGEL stock. Northeast Financial Group Inc. boosted its holdings in shares of NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,848 shares of the company’s stock after purchasing an additional 20,000 shares during the period. Northeast Financial Group Inc. owned 0.50% of NEXGEL worth $82,000 as of its most recent SEC filing. Institutional investors own 2.21% of the company’s stock.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.